John D. Chovan, James R. Cacchillo
Risk Factors, Hematologic Malignancies
Hemic and Lymphatic Diseases | Medical Pathology | Medicine and Health Sciences | Nursing
Multiple myeloma a rare and largely incurable malignant disease the affects the plasma cells. (Bilotti, Gleason, McNeill, and the International Myeloma Foundation Nurse Leadership Board, 2011). Understanding the pathophysiology of Multiple Myeloma (MM) and treatment options in Oncology and Hematology nursing can be difficult. It is the goal of this poster to outline the pathophysiology, prognosis, treatment options available to multiple myeloma patients. Multiple myeloma accounts for about 10% of hematologic malignancies in the U.S. (Kuo, Fenves, Mehta, 2011). MM is the second most common hematologic malignancy with twenty-four thousand new MM cases each year (Bianchi, and Anderson, 2014 )
Crowley, Matthew, "Multiple Myeloma" (2015). Master of Science in Nursing (MSN) Student Scholarship. 98.